Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.
This study tested a new type of PET scan (64Cu-SAR-BBN) to see if it can safely and accurately find prostate cancer that has returned in 53 men whose standard PSMA scans were negative. The goal was to improve detection of cancer recurrence after initial treatment. The study is co…
Phase: PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated May 12, 2026 13:40 UTC